Sialidase – Fc

Press Release

Sialidase – Fc

Sialidase – Fc

Palleon’s lead program, Sialidase-Fc is an enzymatic sialoglycan degrader that is expected to enter clinical testing in 2021 in cancer patient populations defined by an immunosuppressive tumor glycan profile.